Top Addiction Medicine Research Papers

Overall: This rigorous umbrella review is highly relevant to routine alcohol counseling and supports a simple lower-consumption message, but the demonstrated intervention effect is modest and direct clinical benefit remains insufficiently quantified.

Overall: This randomized-trial meta-analysis addresses clinically meaningful pain outcomes and has a clear implication against prolonged opioid therapy, but missing quantitative results and limitations of cross-duration subgroup comparisons weaken certainty.

Overall: This large US comparative-effectiveness study found a modest reduction in nonfatal overdose with buprenorphine-naloxone but no mortality advantage, providing clinically useful yet nonrandomized evidence for outpatient treatment selection after opioid withdrawal.

Overall: This relevant randomized US trial found a clinically meaningful improvement in self-reported cessation with varenicline sampling, but absent objective confirmation, unreported harms, and implementation questions temper confidence and immediate adoption.

Overall: This US trial-informed economic evaluation supports integrating cessation treatment into lung cancer screening, but its strongest long-term benefit claims rely on self-reported quitting and simulation rather than observed clinical outcomes.

Overall: This methodologically rigorous and clinically actionable US guideline addresses important outcomes and a common care gap, but absent quantitative benefit-harm estimates and the lack of high-certainty inpatient-specific evidence limit confidence in its net benefit.

Overall: This randomized trial found a clinically meaningful improvement in youth vaping abstinence using an accessible digital intervention, but very low follow-up substantially weakens confidence and limits immediate adoption.

Overall: This large US quasi-experimental study found sizable gains in postpartum Medicaid continuity and opioid use disorder treatment retention, but residual confounding and the absence of direct health outcomes limit certainty and immediate practice-changing impact.

Overall: This large, precise French primary-care cohort found substantial and sustained mortality reductions during opioid agonist treatment, but residual confounding and limited reporting of harms temper its ability to change US practice.

Overall: This multicenter randomized trial found a large improvement in six-month quitting with sustained telehealth counseling and nicotine replacement therapy, but its oncology-specific setting, intensive workflow, and limited reporting of safety and longer-term clinical outcomes constrain its impact on routine US primary care.